Paying users zone. Data is hidden behind: .
Get 1-month access to Vertex Pharmaceuticals Inc. for $13.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Vertex Pharmaceuticals Inc. pages available today for free:
Enterprise Value (EV)
Current Enterprise Value (EV)
Vertex Pharmaceuticals Inc., current enterprise value calculation
|Current share price (P)|
|No. shares of common stock outstanding|
|US$ in thousands|
|Common equity (market value)1|
|Add: Preferred stock, $0.01 par value; none issued and outstanding (per books)|
|Add: Noncontrolling interest (per books)|
|Add: Credit facility (per books)|
|Add: Current finance lease liabilities (per books)|
|Add: Long-term finance lease liabilities (per books)|
|Total equity and debt|
|Less: Cash and cash equivalents|
|Less: Marketable securities|
|Enterprise value (EV)|
Based on: 10-K (filing date: 2021-02-11).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
Historical Enterprise Value (EV)
Vertex Pharmaceuticals Inc., EV calculation
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Vertex Pharmaceuticals Inc.’s Annual Report.
3 2020 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
|EV||Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments.||Vertex Pharmaceuticals Inc.’s EV increased from 2018 to 2019 but then slightly decreased from 2019 to 2020 not reaching 2018 level.|